Difference between revisions of "Charles B. Nemeroff"

From Powerbase
Jump to: navigation, search
(New page: {{Template:Pharma_Portal_badge}} '''Charles B. Nemeroff''', M.D., Ph.D., is professor and chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami Mille...)
 
(Controversies)
Line 5: Line 5:
 
==Controversies==
 
==Controversies==
  
[[GlaxoSmithKline]] Payment Disclosures
+
'''[[GlaxoSmithKline]] Payment Disclosures'''
  
 
In 2008, Nemeroff was accused of failing to disclose $500,000 worth of payments from [[GSK]]. <ref>Goldstein, J.The Wall Street Journal. 3 October 2008. [http://blogs.wsj.com/health/2008/10/03/grassley-says-emory-psychiatrist-didnt-report-500000-in-payments/ Grassley says Emory Psychiatrist Didnt Report 500,000 in Payments] Accessed 3 February 2010.</ref>
 
In 2008, Nemeroff was accused of failing to disclose $500,000 worth of payments from [[GSK]]. <ref>Goldstein, J.The Wall Street Journal. 3 October 2008. [http://blogs.wsj.com/health/2008/10/03/grassley-says-emory-psychiatrist-didnt-report-500000-in-payments/ Grassley says Emory Psychiatrist Didnt Report 500,000 in Payments] Accessed 3 February 2010.</ref>

Revision as of 04:46, 3 February 2010

Pharma badge.jpg This article is part of the Pharma_Portal project of Spinwatch.

Charles B. Nemeroff, M.D., Ph.D., is professor and chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine and UHealth – University of Miami Health System.[1] Previously, he spent 18 years at the Emory University School of Medicine in Atlanta. He is the former Editor-in-Chief of Neuropsychopharmacology, the journal of the American College of Neuropsychopharmacology(ACNP). [2]

Controversies

GlaxoSmithKline Payment Disclosures

In 2008, Nemeroff was accused of failing to disclose $500,000 worth of payments from GSK. [3] At the time, he was the main investigator of a collaborative project between Emory University, GSK and the US government’s National Institute of Mental Health investigating ‘five novel GSK antidepressants’. [4]

Notes

  1. University of MiamiUM Miller School of Medicine Names New Chair of Psychiatry] Accessed 30 January 2010.
  2. Emory University.Psychiatry: Emory Accessed 2 February 2010.
  3. Goldstein, J.The Wall Street Journal. 3 October 2008. Grassley says Emory Psychiatrist Didnt Report 500,000 in Payments Accessed 3 February 2010.
  4. Grassley, C. 2 October 2008. Senate Letter Accessed 2 February 2010.